Sign In
Buy TWST
$91.55
+0.220 (+0.241%)
At Close: Jul 31, 2026
Twist Bioscience's stock falls 18% after short seller calls the company a 'cash-burning inferno'
08:18am, Tuesday, 15'th Nov 2022
Shares of Twist Bioscience Corp. TWST, -3.48% plunged 18.7% in premarket trading on Tuesday after Scorpion Capital, an activist short seller, described the company as a "cash-burning inferno" and a "'
Palatin Technologies, Inc. (PTN) Reports Q1 Loss, Tops Revenue Estimates
01:55pm, Monday, 14'th Nov 2022 Zacks Investment Research
Palatin Technologies, Inc. (PTN) delivered earnings and revenue surprises of 35.82% and 8.75%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the
Twist Bioscience (TWST) Surges 16.1%: Is This an Indication of Further Gains?
01:12pm, Monday, 14'th Nov 2022 Zacks Investment Research
Twist Bioscience (TWST) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength dow
Twist Bioscience (TWST) Surges 16.1%: Is This an Indication of Further Gains?
09:47am, Monday, 14'th Nov 2022
Twist Bioscience (TWST) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength dow
Immuneering Corporation (IMRX) Reports Q3 Loss, Lags Revenue Estimates
03:15pm, Thursday, 10'th Nov 2022 Zacks Investment Research
Immuneering Corporation (IMRX) delivered earnings and revenue surprises of -2.08% and 92.17%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the s
Aadi Bioscience, Inc. (AADI) Reports Q3 Loss, Tops Revenue Estimates
02:25pm, Wednesday, 09'th Nov 2022 Zacks Investment Research
Aadi Bioscience, Inc. (AADI) delivered earnings and revenue surprises of 9.33% and 18.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stoc
Revance Therapeutics, Inc. (RVNC) Reports Q3 Loss, Tops Revenue Estimates
11:05pm, Tuesday, 08'th Nov 2022 Zacks Investment Research
Revance Therapeutics, Inc. (RVNC) delivered earnings and revenue surprises of -37.65% and 0.90%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for th
Synthetic Biology: Twist Bioscience Revenue Growing From $2 To $200 Million As It Eyes The $186 Billion Antibody Market
01:43pm, Wednesday, 02'nd Nov 2022
The biggest reason why Twist is currently valued at $1.9 billion is the potential to use their silicon DNA synthesis platform for the discovery of new drugs.
Tracking Cathie Wood's ARK Invest 13F Portfolio - Q3 2022 Update
07:10am, Wednesday, 19'th Oct 2022 Seeking Alpha
ARK Invest’s 13F portfolio value decreased from $16.91B to $14.35B this quarter. Click to see the firm's trades for Q3 2022.
Why NVIDIA, Microsoft And Amazon Shares Traded Lower; Here Are 73 Biggest Movers From Friday
09:28am, Monday, 10'th Oct 2022 Benzinga
Gainers
Innovative Eyewear, Inc. (NASDAQ: LUCY) climbed 61.4% to close at $2.63 on abnormally-high volume. The company released its October investor presentation yesterday.
Inventiva S.A. (NASDAQ:
Why Aehr Test Systems Shares Are Trading Higher By Over 19%, Here Are 51 Stocks Moving In Friday's Mid-Day Session
04:27pm, Friday, 07'th Oct 2022 Benzinga
Gainers
Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 108% to $3.3943 on abnormally-high volume. The company released its October investor presentation yesterday.
Minim, Inc. (NASDAQ: MINM) gained
Levi Strauss, Tilray Brands And Some Other Big Stocks Moving Lower On Friday
03:09pm, Friday, 07'th Oct 2022 Benzinga
U.S. stocks traded lower, with the Dow Jones dropping more than 400 points on Friday. Here are some big stocks recording losses in today’s session.
PureTech Health plc (NASDAQ: PRTC) shares dropped
Got $2,000? Consider Buying These 2 Beaten-Down Cathie Wood Stocks at Your Own Risk
02:00pm, Friday, 07'th Oct 2022 The Motley Fool
Their long-term plans are ambitious, but they haven't performed well as investments recently.
Got $2,000? Consider Buying These 2 Beaten-Down Cathie Wood Stocks at Your Own Risk
10:00am, Friday, 07'th Oct 2022
Their long-term plans are ambitious, but they haven't performed well as investments recently.
Where Twist Bioscience Stands With Analysts
05:23pm, Thursday, 06'th Oct 2022 Benzinga
Over the past 3 months, 4 analysts have published their opinion on Twist Bioscience (NASDAQ:TWST) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding
